Response by Flint et al to Letter Regarding Article, "Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment"

Stroke. 2021 Jan;52(1):e39-e40. doi: 10.1161/STROKEAHA.120.032903. Epub 2020 Dec 28.

Authors

Alexander C Flint^{1

2}, Andy L Avins¹, Mai N Nguyen-Huynh^{1

3}

Affiliations

¹ Division of Research, Kaiser Permanente Northern California, Oakland, CA (A.C.F., A.L.A., M.N.N.).
² Department of Neurology, Kaiser Permanente, Redwood City, CA (A.C.F.).
³ Department of Neurology, Kaiser Permanente, Walnut Creek, CA (M.N.N.).

PMID: 33370202
DOI: 10.1161/STROKEAHA.120.032903

No abstract available

Publication types

Letter
Comment

MeSH terms

Fibrinolytic Agents / adverse effects
Humans
Stroke* / drug therapy
Tissue Plasminogen Activator*

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator